PT 02-17 | 8/3/2016 | Hospital No. 242 | Fiscal Year 2017 Medicaid Rates for Administrative Days |
PT 01-17 | 7/5/2016 | Managed Care Organizations No. 112 | Reporting Provider Cotnract Terminations |
PT 03-17 | 8/11/2016 | Hospital No. 243 | Update in Procedure for Submitting Claims Reviews |
PT 04-17 | 8/12/2016 | Medical Supply and Equipment No. 69, Oxygen No. 30 | Future Submissions of Certain DME Preauthorization Requests |
PT 06-17 | 10/3/2016 | Medical Supply and Equipment Transmittal No. 70 | Coverage of Continuous Glucose Monitoring Systems |
PT 10-17 | 10/11/2016 | FQHC | Documenting Behavioral Health Services Billed in FQHC Settings |
PT 09-17 | 10/12/2016 | Nursing Home No. 260 | 2016 Nursing Home Pay-for-Performance Scores |
PT 05-17 | 8/29/2016 | Nursing Home No. 259 | Certification of Need for NF Services |
PT 08-17 | 10/5/2016 | General Provider Transmittal No. 83 | Medicaid Program Updates for Fall 2016 |
PT 07-17 | 10/3/2016 | Hospice Transmittal No. 12 | Hospice Payment Rates for Federal Fiscal Year 2017 |
PT 11-17 | 11/3/2016 | Hospital No. 244 | Distinguishing Between 1184 Newborn Hospital Report of Newborn Process and Hospital Presumptive Eligibility for Newborns |
PT 14-17 | 12/8/2016 | Vision Services No. 1 | Reimbursement for Additional Vision Care Services |
PT 13-17 | 12/1/2016 | Home Health No. 7 | Calendar Year 2017 Home Health Fee Schedule |
PT 15-17 | 12/8/2016 | Hospital No. 245; MCO No. 113; Nursing Home No. 261 | Roles and Responsibilities of Nursing Facilities, Specialty Pediatric Hospitals and Chronic Hospitals when Admitting HealthChoice MCO Members |
PT 17-17 | 12/20/2016 | Beacon Health Options No. 9; MCO No. 115; Laboratory No. 67; Opioid Treatment Provider No. 5; Substance Use Disorder No. 19 | Community-based Medical Laboratory Billing for Substance Use Disorder Screening/Testing for Calendar Year 2017 |
PT 16-17 | 12/19/2016 | Beacon Health Options No. 8; Hospital No. 246; MCO No. 114 | 24 Hour Maximum for Outpatient Observation Stays |
PT 18-17 | 1/5/2017 | Beacon Health Options No. 10; Laboratory No.68; Opioid Treatment Providers No. 6 | Medicaid Billing for Drug Testing and Screening |
PT 20-17 | 2/10/2017 | Beacon Health Options No. 11; Laboratory No. 69; Substance Use Disorder No.20 | |
PT 19-17 | 1/19/2017 | Federally Qualified health Center No. 10 | Enrolling Individual/Rendering Maryland Medicaid Providers |
PT 21-17 | 2/10/2017 | Abortion Clinics No.2, Physicians No. 141 | Coding and Reimbursement Changes for Abortion Procedures |
PT 22-17 | 2/10/2017 | Abortion Clinics No.3 | Correction--Coding and Reimbursement Changes for Abortion Procedures |
PT 24-17 | 3/6/2017 | Nursing Home No. 263 | MDS Validation Reviews |
PT 27-17 | 3/30/2017 | MCO No. 117 | Directing Acting Antiviral (DAA) Coverage |
PT 25-17 | 3/27/2017 | Substance Use Disorder No 21 | Combination of Services, OMT Restrictions |
PT 23-17 | 3/6/2017 | Nursing Home No. 262 | Process for Continued Stay Reviews |
PT 29-17 | 5/9/2017 | Home and Community-Based Options Waiver No. 8; Community First Choice No. 5; Community Personal Assistance Services No. 2 | Criminal Background Checks and Monthly Claims Submission |
PT 28-17 | 4/13/2017 | Hospital No. 248 | Process for Submitting Retroactive Eligibility Cases to Telligen |
PT 26-17 | 3/28/2017 | Substance Use Disorder No. 22 | Combination of Services Limitations Level 1, Level 2.1, Level 2.5 |
PT 30-17 | 5/11/2017 | Hospital No. 249 | Billing for Fee-for-Service Observation Stays |
PT 31-17 | 5/23/2017 | MCO No. 118 | Directing Acting Antiviral (DAA) Coverage Correction |